FLETIKUMAB
UNII 82WG3POL9W

Substance Identification & Data

This profile provides standardized clinical and technical data for Fletikumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 82WG3POL9W.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1357158-22-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
82WG3POL9W
CAS Registry Number
1357158-22-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
FLETIKUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
9876
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
BC-121
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Fletikumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

FLETIKUMAB

Common Names & Synonyms

FLETIKUMAB [INN]
FLETIKUMAB [USAN]
FLETIKUMAB [WHO-DD]
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS IL20 (INTERLEUKIN 20, IL-20)), HUMAN MONOCLONAL ANTIBODY

Technical Codes

ANTI-IL-20
NNC01 09-0012
NNC0109-0012
NNC-0109-0012